CD274 and neoplasm: Additionally, a study conducted by Tumeh et al., showed that in patients affected by metastatic melanoma treated with pembrolizumab, the responders had a higher number of CD8+ T cells, associated with higher PD-1/PD-L1 expression, at the the invasive front of the tumor [54].